Fast-tracking monoclonal antibody therapy for patients with severe asthma
Monoclonal antibody therapies for severe asthma can reduce risky corticosteroid loads, but are still underutilised, writes clinical associate professor Debbie Rigby.
Monoclonal antibody therapies for severe asthma can reduce risky corticosteroid loads, but are still underutilised, writes clinical associate professor Debbie Rigby.
The New South Wales government this week announced reforms that will allow some GPs to treat and potentially diagnose attention-deficit hyperactivity disorder (ADHD).
A new screening tool, The General Practice Sleep Scale, holds promise as a practical, real-world solution to obstructive sleep apnoea underdiagnosis in general practice.
A recent outbreak of polio in Papua New Guinea raises concerns about the potential spread to neighbouring countries, including Australia.
The effectiveness of current workforce targets to improve the quality of aged care remains unclear
The INTEGRATE project offers a concise, algorithmic guideline for schizophrenia pharmacotherapy, co-designed by global experts and those with lived experience.
This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.
Research suggests that persuasive and misleading communication practices are widely used by tobacco and vape industry actors to undermine the development of public policy that threatens their profits.
Social media algorithms reward engagement, but chasing likes can cost doctors dearly, writes Dr Maria Li.